D 2008

Antiapoptotic genes are overexpressed in the group of patients with locally advanced rectal adenocarcinomas who do not respond to neoadjuvant chemoradiotherapy

GARAJOVÁ, Ingrid, Ondřej SLABÝ, Marek SVOBODA, Pavel FABIAN, Jan SILÁK et. al.

Basic information

Original name

Antiapoptotic genes are overexpressed in the group of patients with locally advanced rectal adenocarcinomas who do not respond to neoadjuvant chemoradiotherapy

Name in Czech

Antiapoptotic genes are overexpressed in the group of patients with locally advanced rectal adenocarcinomas who do not respond to neoadjuvant chemoradiotherapy

Authors

GARAJOVÁ, Ingrid (703 Slovakia, guarantor), Ondřej SLABÝ (203 Czech Republic), Marek SVOBODA (203 Czech Republic), Pavel FABIAN (203 Czech Republic), Jan SILÁK (203 Czech Republic), Ilona KOCÁKOVÁ (203 Czech Republic), Ivo KOCÁK (203 Czech Republic), Jana RŮŽIČKOVÁ (203 Czech Republic), Jiří HOCH (203 Czech Republic) and Rostislav VYZULA (203 Czech Republic)

Edition

Volume 6, 2008. Oxford, UK, EJC SUPPLEMENTS, 20th Meeting of the European Association for Cancer Research, p. 116-116, 1 pp. 2008

Publisher

Elsevier Ltd

Other information

Language

English

Type of outcome

Stať ve sborníku

Field of Study

30200 3.2 Clinical medicine

Country of publisher

France

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 3.406

RIV identification code

RIV/00216224:14110/08:00028229

Organization unit

Faculty of Medicine

ISSN

UT WoS

000257919000438

Keywords in English

neoadjuvant therapy fluoropyrimidines radiotherapy rectal adenocarcinomas gene expression profiling DNA arrays
Změněno: 8/4/2010 15:02, prof. RNDr. Ondřej Slabý, Ph.D.

Abstract

V originále

viz sborník Antiapoptotic genes are overexpressed in the group of patients with locally advanced rectal adenocarcinomas who do not respond to neoadjuvant chemoradiotherapy

In Czech

jenom anglicky

Links

NR9076, research and development project
Name: Genomické profilování v predikci odpovědi na chemoradioterapii u pacientů s lokálně pokročilým karcinomem konečníku